HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer.

导出 OA

翻译打印收藏纠错

作者： Franziska M,Würfel ^[1] ; Ralph M,Wirtz ^[2] ; Christoph,Winterhalter ^[1] ; Mario,Taffurelli ^[3] ; Donatella,Santini ^[4] ; Anna,Mandrioli ^[5] ; Elke,Veltrup ^[6] ; Matthias,Rübner ^[1] ; Peter A,Fasching ^[2] ; Wolfgang,Würfel ^[2] ; Claudio,Zamagni ^[3]

作者单位： STRATIFYER Molecular Pathology GmbH, Cologne, Germany. ^[1] Department of Gynecology and Obstetrics, Erlangen University Hospital, Comprehensive Cancer Center Erlangen-EMN, Friedrich Alexander University of Erlangen-Nuremberg (FAU), Erlangen, Germany. ^[2] Intellexon GmbH, Pöcking, Germany. ^[3] General and Breast Surgery Unit University of Bologna S. Orsola Hospital Bologna, Bologna, Italy. ^[4] Pathology Unit S. Orsola Hospital Bologna, Bologna, Italy. ^[5] Addarii Breast and Gynaecological Medical Oncology S. Orsola Hospital Bologna, Bologna, Italy. ^[6]

关键词 HLA-J MHC1 RT-qPCR breast cancer subtypes

DOI 10.1055/a-1128-6664

PMID 33173240

发布时间 2020-11-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Geburtshilfe und Frauenheilkunde

2020年80卷11期

1123-1133页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer.

Geburtshilfe und Frauenheilkunde

相似文献

Geburtshilfe und Frauenheilkunde

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

HLA-J, a Non-Pseudogene as a New Prognostic Marker for Therapy Response and Survival in Breast Cancer.

Geburtshilfe und Frauenheilkunde

相似文献

Geburtshilfe und Frauenheilkunde

相关期刊

检索历史清除